UniProt ID | CCL11_HUMAN | |
---|---|---|
UniProt AC | P51671 | |
Protein Name | Eotaxin | |
Gene Name | CCL11 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 97 | |
Subcellular Localization | Secreted. | |
Protein Description | In response to the presence of allergens, this protein directly promotes the accumulation of eosinophils, a prominent feature of allergic inflammatory reactions. Binds to CCR3.. | |
Protein Sequence | MKVSAALLWLLLIAAAFSPQGLAGPASVPTTCCFNLANRKIPLQRLESYRRITSGKCPQKAVIFKTKLAKDICADPKKKWVQDSMKYLDQKSPTPKP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
53 | Phosphorylation | LESYRRITSGKCPQK HHHHHHHCCCCCCCE | 29.61 | - | |
54 | Phosphorylation | ESYRRITSGKCPQKA HHHHHHCCCCCCCEE | 33.61 | - | |
94 | O-linked_Glycosylation | YLDQKSPTPKP---- HHHHCCCCCCC---- | 51.54 | 9578468 | |
94 | O-linked_Glycosylation | YLDQKSPTPKP---- HHHHCCCCCCC---- | 51.54 | 9578468 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CCL11_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CCL11_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CCL11_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CCL11_HUMAN | CCL11 | physical | 9712872 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
O-linked Glycosylation | |
Reference | PubMed |
"Delayed production of biologically active O-glycosylated forms ofhuman eotaxin by tumor-necrosis-factor-alpha-stimulated dermalfibroblasts."; Noso N., Bartels J., Mallet A.I., Mochizuki M., Christophers E.,Schroeder J.-M.; Eur. J. Biochem. 253:114-122(1998). Cited for: GLYCOSYLATION AT THR-94. |